Peptide companies fall under different regulatory frameworks depending on what they make and who they sell to
Disease activity is classified as: Remission: No active symptoms
We prioritize personalized care and encourage patients to discuss their individual circumstances with our healthcare professionals
83% of peptide-aware Americans want the FDA to make peptides more accessible Days before an FDA advisory committee meets to consider whether seven widely used peptides BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax, and Epitalon should become eligible for compounding, a new survey suggests thats what Americans want
B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T
doi: 10.1038/srep09884